InfanDx

Koln, Germany Founded: 2010 • Age: 16 yrs
In-vitro diagnostic products for newborn acute care conditions are developed.
Request Access

About InfanDx

InfanDx is a company based in Koln (Germany) founded in 2010.. InfanDx has raised $4.74 million across 2 funding rounds from investors including FIL Bros. Capital GmbH, Alluti and Bert Bleicher. InfanDx offers products and services including Neonatal Diagnostics Services. InfanDx operates in a competitive market with competitors including Roche, Cordlife, SonoSite, EKF and NVision Imaging Technologies, among others.

  • Headquarter Koln, Germany
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Infandx Ag
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $4.74 M (USD)

    in 2 rounds

  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of InfanDx

InfanDx offers a comprehensive portfolio of products and services, including Neonatal Diagnostics Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Provides tools for neonatal health monitoring and metabolomics analysis.

People of InfanDx
Headcount 1-10
Employee Profiles 3
Board Members and Advisors 11
Employee Profiles
People
Carola Steins-Rang
Head, Clinical, Regulatory & Quality
People
Gunter Weiss
COO
People
Aisha Munk
Head, Medical Science

Unlock access to complete

Board Members and Advisors
people
Paul Owsianowski
Board Member
people
Wolfgang Schwandner
Board Member
people
Matthias Keller
Scientific Advisor
people
Lena Hellström-Westas
Scientific Advisor

Unlock access to complete

Funding Insights of InfanDx

InfanDx has successfully raised a total of $4.74M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round

    (13 Jul 2021)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2022 Amount Series A - InfanDx Valuation

investors

Jul, 2021 Amount Series A - InfanDx Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in InfanDx

InfanDx has secured backing from 4 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include FIL Bros. Capital GmbH, Alluti and Bert Bleicher. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
A single family office focused on smart investments is operated.
Founded Year Domain Location
-
Founded Year Domain Location

Bert Bleicher

Angel investor focusing on Indian startups, tech enthusiast, and strategic advisor
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by InfanDx

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - InfanDx

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Infandx Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of InfanDx

InfanDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Roche, Cordlife, SonoSite, EKF and NVision Imaging Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Pharmaceuticals and diagnostics kits are developed for various diseases.
domain founded_year HQ Location
Cordlife is engaged in cord blood banking and diagnostics.
domain founded_year HQ Location
Hand-carried ultrasound systems for medical specialties are developed and distributed.
domain founded_year HQ Location
Point-of-care and laboratory blood analyzers are developed by EKF.
domain founded_year HQ Location
Medical imaging is provided through quantum technologies.
domain founded_year HQ Location
Drug testing services are offered for clinical trials and workplaces.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Infandx

Frequently Asked Questions about InfanDx

When was InfanDx founded?

InfanDx was founded in 2010 and raised its 1st funding round 11 years after it was founded.

Where is InfanDx located?

InfanDx is headquartered in Koln, Germany. It is registered at Koln, North Rhine-westphalia, Germany.

Who is the current CEO of InfanDx?

Achim Plum is the current CEO of InfanDx.

Is InfanDx a funded company?

InfanDx is a funded company, having raised a total of $4.74M across 2 funding rounds to date. The company's 1st funding round was a Series A of $4.74M, raised on Jul 13, 2021.

What does InfanDx do?

InfanDx was founded in 2010 in Cologne, Germany, as a developer of in-vitro diagnostic products focused on acute and critical care for newborns. Operations center on tools like the HypoxE test, which identifies perinatal asphyxia from oxygen deficits at birth, assesses hypoxic-ischemic encephalopathy prognosis, and detects related brain injuries. The sector involves medical diagnostics for neonatal health challenges.

Who are the top competitors of InfanDx?

InfanDx's top competitors include Cordlife, Roche and EKF.

What products or services does InfanDx offer?

InfanDx offers Neonatal Diagnostics Services.

Who are InfanDx's investors?

InfanDx has 4 investors. Key investors include FIL Bros. Capital GmbH, Alluti, Bert Bleicher, and Jochen Tschunke.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available